Indefinite Delivery Contract SPE2D020D0008
Award Date
7/9/20
Last Date to Order
7/9/30
Federal Agency
Medical Supply Chain
Awardee
Marlex Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The provided information describes a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Marlex Pharmaceuticals Inc., a minority-owned small disadvantaged business. The contract (36F79719D0161) is for the provision of pharmaceuticals and medical products under Schedule 65 I B, covering a wide range of generic drugs such as antibiotics, pain relievers, allergy treatments, muscle relaxants, and cardiovascular medications. The contract has a ceiling...
This indefinite delivery contract (IDC) was awarded by the National Acquisition Center, a civilian federal agency, to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business. The contract, valued at $14,155,681.05, is for the supply of ezetimibe tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The period of performance is one year with four one-year option periods, running from April 28, 2024 to...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency within the Department of Veterans Affairs (VA), to Marlex Pharmaceuticals Inc., a minority-owned and self-certified small disadvantaged business manufacturer of generic pharmaceutical and medical products. The $5.7 million contract covers the supply of alendronate tablets in different sizes to support the medical needs of the VA, Bureau of Prisons, and Indian Health Service. The contract has...
The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Marlex Pharmaceuticals Inc. to provide baclofen tablets. The contract has a potential value of $17,702,067.50 and a period of performance from July 1, 2020, to June 30, 2025, with four one-year option periods. Marlex Pharmaceuticals Inc., a minority-owned and small disadvantaged business, is the sole provider of baclofen tablets under this contract. The agency estimates...
The federal contract IDV is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Marlex Pharmaceuticals Inc., a minority-owned, small disadvantaged business located in New Castle, Delaware. The $88,000,000 multiple-award contract, with a period of performance through February 1, 2030, is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS contract code 65 I B. Marlex Pharmaceuticals holds several significant...
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite delivery contract to Marlex Pharmaceuticals Inc. to supply probenecid 500mg tablets with a potential value of $5.4 million over a five-year base period and four option years. Place of performance will be in New Castle, Delaware. No set-aside was applied to the original pre-solicitation notice seeking annual supplies of approximately 18,719 bottles of probenecid tablets to support healthcare...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract, which is valid through November 2026, covers an extensive portfolio of branded...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $4,999,999 single-award IDC, which is valid through March 2036, covers an extensive...
The Defense Logistics Agency (DLA) has awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The $499,999,999 IDC, valid through November 2026, covers an extensive portfolio of branded and generic...
The Defense Logistics Agency (DLA) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 through November 2026. This IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities nationwide. The contract covers an...